Speaking today at the White Rose Bioscience Forum in York (Tuesday 31 October), Wallder told delegates:
“For early stage life science companies, building a successful management team is the ‘holy grail’. The best management can make ordinary technology fly, but poor management will very often result in companies with even the best technology either not achieving their full potential – or worse, failing miserably!”
Today's life science executives need a broader range of skills and competencies than ever before: raising funds, managing complex intellectual property and licensing issues and not least leading and managing their staff - all whilst aiming for realistic exit strategies for investors.
“Building successful management teams is about hiring the right people at the right time,” Wallder says. ”A great start-up CEO will not necessarily be the right person at the series B investment stage, or at trade sale or IPO.”
Wallder advises that the UK should try to emulate the US, where life science companies take a different view to management: “In the US, the mindset is different”, he explains. “It’s recognised that the skill set required throughout a company’s life will be different at specific stages, and because there are so few people with the necessary skills and experience to drive a company from start-up to plc, it is common practice for senior management to be replaced during the company’s progression.”
However, in the US this is not viewed as failure on the part of the outgoing management – it’s simply a pragmatic step that ensures the continued commercial health of the company. Says Wallder: “The management is seen as having effectively completed the job they were hired to do at that particular stage. The beauty of the US practice is that it frees up talented executives for other companies, who are at the stage where they could use their particular skills and experience.”
In the UK, the perception of success and failure is different, he says, an outgoing senior management can be seen in a negative light, rather than congratulated for successfully taking the company to its next stage.
“The UK practice of hiring a CEO and then expecting that person to be all things to all people at all stages is unrealistic. This is particularly so when the founding academic takes on the CEO role. It is the responsibility of the company board and its investors to allow senior management to play to their strengths but to recognise when new strengths are required. The company will be more attractive to investors in later funding rounds if this issue is addressed before approaches for funding are made,” he says.
Jo Kelly | alfa
Water forms 'spine of hydration' around DNA, group finds
26.05.2017 | Cornell University
How herpesviruses win the footrace against the immune system
26.05.2017 | Helmholtz-Zentrum für Infektionsforschung
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
26.05.2017 | Life Sciences
26.05.2017 | Life Sciences
26.05.2017 | Physics and Astronomy